2,520
Views
139
CrossRef citations to date
0
Altmetric
Original

The involvement of lipid rafts in Alzheimer's disease (Review)

, , &
Pages 111-122 | Received 07 Oct 2005, Published online: 09 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (10)

Chaoqun Wang, Yikai Shou, Jie Pan, Yue Du, Cuiqing Liu & Huanhuan Wang. (2019) The relationship between cholesterol level and Alzheimer’s disease-associated APP proteolysis/Aβ metabolism. Nutritional Neuroscience 22:7, pages 453-463.
Read now
Hui Chen, Yue Du, Shuai Liu, Baojin Ge, Yong Ji & Guowei Huang. (2019) Association between serum cholesterol levels and Alzheimer’s disease in China: a case-control study. International Journal of Food Sciences and Nutrition 70:4, pages 405-411.
Read now
Zhiyou Cai, Guanghui Chen, Wenbo He, Ming Xiao & Liang-Jun Yan. (2015) Activation of mTOR: a culprit of Alzheimer’s disease?. Neuropsychiatric Disease and Treatment 11, pages 1015-1030.
Read now
Elizabeth Drolle, Francis Hane, Brenda Lee & Zoya Leonenko. (2014) Atomic force microscopy to study molecular mechanisms of amyloid fibril formation and toxicity in Alzheimer’s disease. Drug Metabolism Reviews 46:2, pages 207-223.
Read now
Federica Belluti, Angela Rampa, Silvia Gobbi & Alessandra Bisi. (2013) Small-molecule inhibitors/modulators of amyloid-β peptide aggregation and toxicity for the treatment of Alzheimer's disease: a patent review (2010 – 2012). Expert Opinion on Therapeutic Patents 23:5, pages 581-596.
Read now
Alina Solomon & Miia Kivipelto. (2009) Cholesterol-modifying strategies for Alzheimer’s disease. Expert Review of Neurotherapeutics 9:5, pages 695-709.
Read now
Heledd H Griffiths, Isobel J Morten & Nigel M Hooper. (2008) Emerging and potential therapies for Alzheimer's disease. Expert Opinion on Therapeutic Targets 12:6, pages 693-704.
Read now
Walter J Lukiw. (2008) Emerging amyloid beta (Ab) peptide modulators for the treatment of Alzheimer's disease (AD). Expert Opinion on Emerging Drugs 13:2, pages 255-271.
Read now
James F Whitfield. (2006) Can statins put the brakes on Alzheimer’s disease?. Expert Opinion on Investigational Drugs 15:12, pages 1479-1485.
Read now

Articles from other publishers (129)

Lucas J. Handlin & Gucan Dai. (2023) Direct regulation of the voltage sensor of HCN channels by membrane lipid compartmentalization. Nature Communications 14:1.
Crossref
Pierluigi Reveglia, Carmela Paolillo, Antonella Angiolillo, Gabriella Ferretti, Ruggero Angelico, Rossana Sirabella, Gaetano Corso, Carmela Matrone & Alfonso Di Costanzo. (2023) A Targeted Mass Spectrometry Approach to Identify Peripheral Changes in Metabolic Pathways of Patients with Alzheimer’s Disease. International Journal of Molecular Sciences 24:11, pages 9736.
Crossref
Zixuan Yuan & Scott B. Hansen. (2023) Cholesterol Regulation of Membrane Proteins Revealed by Two-Color Super-Resolution Imaging. Membranes 13:2, pages 250.
Crossref
Gucan Dai. (2022) Neuronal KCNQ2/3 channels are recruited to lipid raft microdomains by palmitoylation of BACE1. Journal of General Physiology 154:4.
Crossref
Jessica Sarahi Alavez-Rubio & Teresa Juárez-Cedillo. 2022. Current Thoughts on Dementia. Current Thoughts on Dementia 357 385 .
Guido Santos & Mario Díaz. (2021) Dimensional Changes in Lipid Rafts from Human Brain Cortex Associated to Development of Alzheimer’s Disease. Predictions from an Agent-Based Mathematical Model. International Journal of Molecular Sciences 22:22, pages 12181.
Crossref
Sandra den Hoedt, Simone M. Crivelli, Frank P. J. Leijten, Mario Losen, Jo A. A. Stevens, Marina Mané-Damas, Helga E. de Vries, Jochen Walter, Mina Mirzaian, Eric J. G. Sijbrands, Johannes M. F. G. Aerts, Adrie J. M. Verhoeven, Pilar Martinez-Martinez & Monique T. Mulder. (2021) Effects of Sex, Age, and Apolipoprotein E Genotype on Brain Ceramides and Sphingosine-1-Phosphate in Alzheimer’s Disease and Control Mice. Frontiers in Aging Neuroscience 13.
Crossref
Irena Roterman, Katarzyna Stapor, Piotr Fabian & Leszek Konieczny. (2021) In Silico Modeling of the Influence of Environment on Amyloid Folding Using FOD-M Model. International Journal of Molecular Sciences 22:19, pages 10587.
Crossref
Doris Loh & Russel J. Reiter. (2021) Melatonin: Regulation of Biomolecular Condensates in Neurodegenerative Disorders. Antioxidants 10:9, pages 1483.
Crossref
Hiromitsu Toshikawa, Akihiro Ikenaka, Li Li, Yoko Nishinaka-Arai, Akira Niwa, Akira Ashida, Yasuhiro Kazuki, Tatsutoshi Nakahata, Hiroshi Tamai, David W. Russell & Megumu K. Saito. (2021) N-Acetylcysteine prevents amyloid-β secretion in neurons derived from human pluripotent stem cells with trisomy 21. Scientific Reports 11:1.
Crossref
Hao Wang, Joshua A. KulasChao Wang, David M. Holtzman, Heather A. Ferris & Scott B. Hansen. (2021) Regulation of beta-amyloid production in neurons by astrocyte-derived cholesterol. Proceedings of the National Academy of Sciences 118:33.
Crossref
Lumi Zhang, Lingxiao Li, Fanxia Meng, Jie Yu, Fangping He, Yajie Lin, Yujie Su, Mengjie Hu, Xiaoyan Liu, Yang Liu, Benyan Luo & Guoping Peng. (2021) Serum Metabolites Differentiate Amnestic Mild Cognitive Impairment From Healthy Controls and Predict Early Alzheimer's Disease via Untargeted Lipidomics Analysis. Frontiers in Neurology 12.
Crossref
Yang-Yang Wang, Yan-Ping Sun, Yu-Meng Luo, Dong-Hui Peng, Xiao Li, Bing-You Yang, Qiu-Hong Wang & Hai-Xue Kuang. (2021) Biomarkers for the Clinical Diagnosis of Alzheimer’s Disease: Metabolomics Analysis of Brain Tissue and Blood. Frontiers in Pharmacology 12.
Crossref
Weiwei Yu, Haiqiang Jin & Yining Huang. (2021) Mitochondria-associated membranes (MAMs): a potential therapeutic target for treating Alzheimer’s disease. Clinical Science 135:1, pages 109-126.
Crossref
Ricardo Capone, Ajit Tiwari, Arina Hadziselimovic, Yelena Peskova, James M. Hutchison, Charles R. Sanders & Anne K. Kenworthy. (2021) The C99 domain of the amyloid precursor protein resides in the disordered membrane phase. Journal of Biological Chemistry 296, pages 100652.
Crossref
Martina Hrabinova, Jaroslav Pejchal, Tomas Kucera, Daniel Jun, Monika Schmidt & Ondrej Soukup. (2020) Is It the Twilight of BACE1 Inhibitors?. Current Neuropharmacology 19:1, pages 61-77.
Crossref
Rishi R. Agrawal, Jorge Montesinos, Delfina Larrea, Estela Area-Gomez & Marta Pera. (2020) The silence of the fats: A MAM’s story about Alzheimer. Neurobiology of Disease 145, pages 105062.
Crossref
Jorge Montesinos, Marta Pera, Delfina Larrea, Cristina Guardia‐Laguarta, Rishi R Agrawal, Kevin R Velasco, Taekyung D Yun, Irina G Stavrovskaya, Yimeng Xu, So Yeon Koo, Amanda M Snead, Andrew A Sproul & Estela Area‐Gomez. (2020) The Alzheimer's disease‐associated C99 fragment of APP regulates cellular cholesterol trafficking. The EMBO Journal 39:20.
Crossref
Sibel Kara, Lukas Amon, Jennifer J. Lühr, Falk Nimmerjahn, Diana Dudziak & Anja Lux. (2020) Impact of Plasma Membrane Domains on IgG Fc Receptor Function. Frontiers in Immunology 11.
Crossref
Marta Pera, Jorge Montesinos, Delfina Larrea, Rishi R. Agrawal, Kevin R. Velasco, Irina G. Stavrovskaya, Taekyung D. Yun & Estela Area-Gomez. 2020. Metabolic and Bioenergetic Drivers of Neurodegenerative Disease: Neurodegenerative Disease Research and Commonalities with Metabolic Diseases. Metabolic and Bioenergetic Drivers of Neurodegenerative Disease: Neurodegenerative Disease Research and Commonalities with Metabolic Diseases 235 278 .
Jessica Sarahi Alavez-Rubio & Teresa Juarez-Cedillo. (2019) ACAT1 as a Therapeutic Target and its Genetic Relationship with Alzheimer's Disease. Current Alzheimer Research 16:8, pages 699-709.
Crossref
Alexey M. Petrov, Natalia Mast, Yong Li & Irina A. Pikuleva. (2019) The key genes, phosphoproteins, processes, and pathways affected by efavirenz‐activated CYP46A1 in the amyloid‐decreasing paradigm of efavirenz treatment. The FASEB Journal 33:8, pages 8782-8798.
Crossref
Camila Fabiani & Silvia S. Antollini. (2019) Alzheimer’s Disease as a Membrane Disorder: Spatial Cross-Talk Among Beta-Amyloid Peptides, Nicotinic Acetylcholine Receptors and Lipid Rafts. Frontiers in Cellular Neuroscience 13.
Crossref
Frits Kamp, Holger A. Scheidt, Edith Winkler, Gabriele Basset, Hannes Heinel, James M. Hutchison, Loren M. LaPointe, Charles R. Sanders, Harald Steiner & Daniel Huster. (2018) Bexarotene Binds to the Amyloid Precursor Protein Transmembrane Domain, Alters Its α-Helical Conformation, and Inhibits γ-Secretase Nonselectively in Liposomes. ACS Chemical Neuroscience 9:7, pages 1702-1713.
Crossref
Sindhu Ramesh, Manoj Govindarajulu, Vishnu Suppiramaniam, Timothy Moore & Muralikrishnan Dhanasekaran. (2018) Autotaxin–Lysophosphatidic Acid Signaling in Alzheimer’s Disease. International Journal of Molecular Sciences 19:7, pages 1827.
Crossref
Varda Shoshan-Barmatz, Edna Nahon-Crystal, Anna Shteinfer-Kuzmine & Rajeev Gupta. (2018) VDAC1, mitochondrial dysfunction, and Alzheimer's disease. Pharmacological Research 131, pages 87-101.
Crossref
Mouhamed Alsaqati, Rhian S Thomas & Emma J Kidd. (2018) Proteins Involved in Endocytosis Are Upregulated by Ageing in the Normal Human Brain: Implications for the Development of Alzheimer’s Disease. The Journals of Gerontology: Series A 73:3, pages 289-298.
Crossref
Anthony G. Boghdadi, Leon Teo & James A. Bourne. (2017) The Involvement of the Myelin-Associated Inhibitors and Their Receptors in CNS Plasticity and Injury. Molecular Neurobiology 55:3, pages 1831-1846.
Crossref
Estela Area-Gomez, Ad de Groof, Eduardo Bonilla, Jorge Montesinos, Kurenai Tanji, Istvan Boldogh, Liza Pon & Eric A. Schon. (2018) A key role for MAM in mediating mitochondrial dysfunction in Alzheimer disease. Cell Death & Disease 9:3.
Crossref
Liu He, Yuqi Jiang, Kai Liu, Victoria Gomez-Murcia, Xiaopin Ma, Alejandro Torrecillas, Qun Chen, Xiongwei Zhu, Edward Lesnefsky, Juan C. Gomez-Fernandez, Bin Xu & Shijun Zhang. (2018) Insights into the Impact of a Membrane-Anchoring Moiety on the Biological Activities of Bivalent Compounds As Potential Neuroprotectants for Alzheimer’s Disease. Journal of Medicinal Chemistry 61:3, pages 777-790.
Crossref
Marta Pera, Delfina Larrea, Cristina Guardia‐Laguarta, Jorge Montesinos, Kevin R Velasco, Rishi R Agrawal, Yimeng Xu, Robin B Chan, Gilbert Di Paolo, Mark F Mehler, Geoffrey S Perumal, Frank P Macaluso, Zachary Z Freyberg, Rebeca Acin‐Perez, Jose Antonio Enriquez, Eric A Schon & Estela Area‐Gomez. (2017) Increased localization of APP ‐C99 in mitochondria‐associated ER membranes causes mitochondrial dysfunction in Alzheimer disease . The EMBO Journal 36:22, pages 3356-3371.
Crossref
Rhian S. Thomas, Mouhamed Alsaqati, Justin S. Bice, Martha Hvoslef-Eide, Mark A. Good & Emma J. Kidd. (2017) Alterations in endocytic protein expression with increasing age in the transgenic APP695 V717I London mouse model of amyloid pathology. NeuroReport 28:15, pages 963-968.
Crossref
Amy S. Yokoyama, John C. Rutledge & Valentina Medici. (2017) DNA methylation alterations in Alzheimer’s disease. Environmental Epigenetics 3:2.
Crossref
Raquel Marin, Noemí Fabelo, Virginia Martín, Paula Garcia-Esparcia, Isidre Ferrer, David Quinto-Alemany & Mario Díaz. (2017) Anomalies occurring in lipid profiles and protein distribution in frontal cortex lipid rafts in dementia with Lewy bodies disclose neurochemical traits partially shared by Alzheimer's and Parkinson's diseases. Neurobiology of Aging 49, pages 52-59.
Crossref
Shijun Zhang, John M. Saathoff & Liu He. 2017. Design of Hybrid Molecules for Drug Development. Design of Hybrid Molecules for Drug Development 219 237 .
Renata Kowalczyk, Paul W. R. Harris, Geoffrey M. Williams, Sung-Hyun Yang & Margaret A. Brimble. 2017. Peptides and Peptide-based Biomaterials and their Biomedical Applications. Peptides and Peptide-based Biomaterials and their Biomedical Applications 185 227 .
Qian He, Qing Li, Jiangang Zhao, Tianfeng Wu, Lu Ji, Guowei Huang & Fei Ma. (2016) Relationship between plasma lipids and mild cognitive impairment in the elderly Chinese: a case-control study. Lipids in Health and Disease 15:1.
Crossref
Emilia Laudati, Andrew S. Gilder, Michael S. Lam, Roberta Misasi, Maurizio Sorice, Steven L. Gonias & Elisabetta Mantuano. (2016) The activities of LDL Receptor-related Protein-1 (LRP1) compartmentalize into distinct plasma membrane microdomains. Molecular and Cellular Neuroscience 76, pages 42-51.
Crossref
Lakshini H. S. Mendis, Angus C. Grey, Richard L. M. Faull & Maurice A. Curtis. (2016) Hippocampal lipid differences in Alzheimer's disease: a human brain study using matrix‐assisted laser desorption/ionization‐imaging mass spectrometry. Brain and Behavior 6:10.
Crossref
Kamil Bienias, Anna Fiedorowicz, Anna Sadowska, Sławomir Prokopiuk & Halina Car. (2016) Regulation of sphingomyelin metabolism. Pharmacological Reports 68:3, pages 570-581.
Crossref
Massimo Aureli, Laura Mauri, Maria Grazia Ciampa, Alessandro Prinetti, Gino Toffano, Cynthia Secchieri & Sandro Sonnino. (2015) GM1 Ganglioside: Past Studies and Future Potential. Molecular Neurobiology 53:3, pages 1824-1842.
Crossref
Naoki Yamamoto, Yoko Fujii, Rika Kasahara, Mamoru Tanida, Kentaro Ohora, Yoko Ono, Kenji Suzuki & Kazuya Sobue. (2016) Simvastatin and atorvastatin facilitates amyloid ?-protein degradation in extracellular spaces by increasing neprilysin secretion from astrocytes through activation of MAPK/Erk1/2 pathways. Glia, pages n/a-n/a.
Crossref
Takashi Amemori, Pavla Jendelova, Jiri Ruzicka, Lucia Urdzikova & Eva Sykova. (2015) Alzheimer’s Disease: Mechanism and Approach to Cell Therapy. International Journal of Molecular Sciences 16:11, pages 26417-26451.
Crossref
Jeremy E. Chojnacki, Kai Liu, John M. Saathoff & Shijun Zhang. (2015) Bivalent ligands incorporating curcumin and diosgenin as multifunctional compounds against Alzheimer?s disease. Bioorganic & Medicinal Chemistry 23:22, pages 7324-7331.
Crossref
Alexander C. Y. Foo, Brandon G. R. Harvey, Jeff J. Metz & Natalie K. Goto. (2015) Influence of hydrophobic mismatch on the catalytic activity of E scherichia coli GlpG rhomboid protease . Protein Science 24:4, pages 464-473.
Crossref
Li Liu, Ke Zhang, Liang Tan, Yu-Hua Chen & Yun-Peng Cao. (2015) Alterations in Cholesterol and Ganglioside GM1 Content of Lipid Rafts in Platelets From Patients With Alzheimer Disease. Alzheimer Disease & Associated Disorders 29:1, pages 63-69.
Crossref
C. Fernandez-Echevarria, M. Díaz, I. Ferrer, A. Canerina-Amaro & R. Marin. (2014) Aβ promotes VDAC1 channel dephosphorylation in neuronal lipid rafts. Relevance to the mechanisms of neurotoxicity in Alzheimer’s disease. Neuroscience 278, pages 354-366.
Crossref
Noemí Fabelo, Virginia Martín, Raquel Marín, Dolores Moreno, Isidre Ferrer & Mario Díaz. (2014) Altered lipid composition in cortical lipid rafts occurs at early stages of sporadic Alzheimer's disease and facilitates APP/BACE1 interactions. Neurobiology of Aging 35:8, pages 1801-1812.
Crossref
Rajesh Singh Yadav & Neeraj Kumar Tiwari. (2014) Lipid Integration in Neurodegeneration: An Overview of Alzheimer’s Disease. Molecular Neurobiology 50:1, pages 168-176.
Crossref
Tomokazu Nishikawa, Tetsuya Takahashi, Masahiro Nakamori, Yu Yamazaki, Takashi Kurashige, Yoshito Nagano, Yoshihiko Nishida, Yuishin Izumi & Masayasu Matsumoto. (2014) Phosphatidylinositol‐4,5‐bisphosphate is enriched in granulovacuolar degeneration bodies and neurofibrillary tangles. Neuropathology and Applied Neurobiology 40:4, pages 489-501.
Crossref
Eduardo Luiz Gasnhar Moreira, Jade de Oliveira, Daiane Fátima Engel, Roger Walz, Andreza Fabro de Bem, Marcelo Farina & Rui Daniel S. Prediger. (2013) Hypercholesterolemia induces short-term spatial memory impairments in mice: up-regulation of acetylcholinesterase activity as an early and causal event?. Journal of Neural Transmission 121:4, pages 415-426.
Crossref
Anders A. F. Sima. 2014. Studies in Diabetes. Studies in Diabetes 127 147 .
R. Marin, V. Casañas, J. A. Pérez, N. Fabelo, C. E. Fernandez & M. Diaz. (2013) Oestrogens as M odulators of N euronal Si gnalosomes and B rain L ipid H omeostasis R elated to P rotection A gainst N eurodegeneration . Journal of Neuroendocrinology 25:11, pages 1104-1115.
Crossref
Peter G. Billcliff, Ruth Rollason, Ian Prior, Dylan M. Owen, Katharina Gaus & George Banting. (2013) CD317/tetherin is an organiser of membrane microdomains. Journal of Cell Science 126:7, pages 1553-1564.
Crossref
Jochen Walter & Gerhild van Echten-Deckert. (2013) Cross-talk of membrane lipids and Alzheimer-related proteins. Molecular Neurodegeneration 8:1, pages 34.
Crossref
D.S. Folk, F. Kielar & K.J. Franz. 2013. Comprehensive Inorganic Chemistry II. Comprehensive Inorganic Chemistry II 207 240 .
Jiaqi Yao, Daniel Ho, Noel Y. Calingasan, Nina H. Pipalia, Michael T. Lin & M. Flint Beal. (2012) Neuroprotection by cyclodextrin in cell and mouse models of Alzheimer disease. Journal of Experimental Medicine 209:13, pages 2501-2513.
Crossref
Kai Liu, Ronak Gandhi, Jiangmin Chen & Shijun Zhang. (2012) Bivalent Ligands Targeting Multiple Pathological Factors Involved in Alzheimer's Disease. ACS Medicinal Chemistry Letters 3:11, pages 942-946.
Crossref
Gerhild van Echten-Deckert & Jochen Walter. (2012) Sphingolipids: Critical players in Alzheimer?s disease. Progress in Lipid Research 51:4, pages 378-393.
Crossref
Paola Gamba, Gabriella Testa, Barbara Sottero, Simona Gargiulo, Giuseppe Poli & Gabriella Leonarduzzi. (2012) The link between altered cholesterol metabolism and Alzheimer's disease. Annals of the New York Academy of Sciences 1259:1, pages 54-64.
Crossref
Oliver Holmes, Swetha Paturi, Wenjuan Ye, Michael S. Wolfe & Dennis J. Selkoe. (2012) Effects of Membrane Lipids on the Activity and Processivity of Purified γ-Secretase. Biochemistry 51:17, pages 3565-3575.
Crossref
Kazumi Motoki, Hideaki Kume, Akiko Oda, Akira Tamaoka, Ai Hosaka, Fuyuki Kametani & Wataru Araki. (2012) Neuronal β‐amyloid generation is independent of lipid raft association of β‐secretase BACE1: analysis with a palmitoylation‐deficient mutant. Brain and Behavior 2:3, pages 270-282.
Crossref
Gemma Fabrias, Jose Muñoz-Olaya, Francesca Cingolani, Paola Signorelli, Josefina Casas, Vincenzo Gagliostro & Riccardo Ghidoni. (2012) Dihydroceramide desaturase and dihydrosphingolipids: Debutant players in the sphingolipid arena. Progress in Lipid Research 51:2, pages 82-94.
Crossref
Sally Hunter & Carol Brayne. (2012) Relationships between the amyloid precursor protein and its various proteolytic fragments and neuronal systems. Alzheimer's Research & Therapy 4:2, pages 10.
Crossref
Z. Pernber, K. Blennow, N. Bogdanovic, J.-E. M?nsson & M. Blomqvist. (2012) Altered Distribution of the Gangliosides GM1 and GM2 in Alzheimer?s Disease. Dementia and Geriatric Cognitive Disorders 33:2-3, pages 174-188.
Crossref
Philipp Linning, Ute Haussmann, Isaak Beyer, Sebastian Weidlich, Heinke Schieb, Jens Wiltfang, Hans-Wolfgang Klafki & Hans-Joachim Kn?lker. (2012) Optimisation of BACE1 inhibition of tripartite structures by modification of membrane anchors, spacers and pharmacophores ? development of potential agents for the treatment of Alzheimer's disease. Organic & Biomolecular Chemistry 10:41, pages 8216.
Crossref
Suresh Kumar, Edward J. Okello & J. Robin Harris. 2012. Protein Aggregation and Fibrillogenesis in Cerebral and Systemic Amyloid Disease. Protein Aggregation and Fibrillogenesis in Cerebral and Systemic Amyloid Disease 295 326 .
Anders A. F. Sima & Wei-Xian Zhang. 2012. Diabetes & C-Peptide. Diabetes & C-Peptide 93 109 .
Ya Hui Hung, Ashley I. Bush & Robert A. Cherny. 2012. Metal Ion in Stroke. Metal Ion in Stroke 609 645 .
Marco Diociaiuti, Maria Cristina Gaudiano & Fiorella Malchiodi-Albedi. (2011) The Slowly Aggregating Salmon Calcitonin: A Useful Tool for the Study of the Amyloid Oligomers Structure and Activity. International Journal of Molecular Sciences 12:12, pages 9277-9295.
Crossref
Rhian S. Thomas, Mariah J. Lelos, Mark A. Good & Emma J. Kidd. (2011) Clathrin-mediated endocytic proteins are upregulated in the cortex of the Tg2576 mouse model of Alzheimer’s disease-like amyloid pathology. Biochemical and Biophysical Research Communications 415:4, pages 656-661.
Crossref
Ling Chao & Susan Daniel. (2011) Measuring the Partitioning Kinetics of Membrane Biomolecules Using Patterned Two-Phase Coexistant Lipid Bilayers. Journal of the American Chemical Society 133:39, pages 15635-15643.
Crossref
Si JinFan ZhouFoad KatiraiPin-Lan Li. (2011) Lipid Raft Redox Signaling: Molecular Mechanisms in Health and Disease. Antioxidants & Redox Signaling 15:4, pages 1043-1083.
Crossref
J.-H. Kim, S.-M. Ee, J. Jittiwat, E.-S. Ong, A.A. Farooqui, A.M. Jenner & W.-Y. Ong. (2011) Increased expression of acyl-coenzyme A: cholesterol acyltransferase-1 and elevated cholesteryl esters in the hippocampus after excitotoxic injury. Neuroscience 185, pages 125-134.
Crossref
Carmen Noelker, Harald Hampel & Richard Dodel. (2012) Blood-Based Protein Biomarkers for Diagnosis and Classification of Neurodegenerative Diseases. Molecular Diagnosis & Therapy 15:2, pages 83-102.
Crossref
David Hicks, Danielle John, Natalia Z. Makova, Zaineb Henderson, Natalia N. Nalivaeva & Anthony J. Turner. (2011) Membrane targeting, shedding and protein interactions of brain acetylcholinesterase. Journal of Neurochemistry 116:5, pages 742-746.
Crossref
Paul H. Axelsen, Hiroaki KomatsuIan V. J. Murray. (2011) Oxidative Stress and Cell Membranes in the Pathogenesis of Alzheimer's Disease. Physiology 26:1, pages 54-69.
Crossref
P. D. Bregestovski. (2011) Architecture of receptor-operated ion channels of biological membranes. Biophysics 56:1, pages 51-64.
Crossref
Wei Rao, R. Elwyn Isaac & Jeffrey N. Keen. (2011) An analysis of the Caenorhabditis elegans lipid raft proteome using geLC-MS/MS. Journal of Proteomics 74:2, pages 242-253.
Crossref
Jo V. Rushworth & Nigel M. Hooper. (2011) Lipid Rafts: Linking Alzheimer's Amyloid- β Production, Aggregation, and Toxicity at Neuronal Membranes . International Journal of Alzheimer's Disease 2011, pages 1-14.
Crossref
Jian Zhong. (2011) From simple to complex: investigating the effects of lipid composition and phase on the membrane interactions of biomolecules using in situ atomic force microscopy. Integrative Biology 3:6, pages 632.
Crossref
Antoine Piau, F. Nourhashémi, C. Hein, C. Caillaud & B. Vellas. (2011) Progress in the development of new drugs in Alzheimer’s disease. The journal of nutrition, health & aging 15:1, pages 45-57.
Crossref
Nikolai D. Belyaev, Katherine A.B. Kellett, Caroline Beckett, Natalia Z. Makova, Timothy J. Revett, Natalia N. Nalivaeva, Nigel M. Hooper & Anthony J. Turner. (2010) The Transcriptionally Active Amyloid Precursor Protein (APP) Intracellular Domain Is Preferentially Produced from the 695 Isoform of APP in a β-Secretase-dependent Pathway*. Journal of Biological Chemistry 285:53, pages 41443-41454.
Crossref
Anders A. F. Sima. (2010) Encephalopathies: the emerging diabetic complications. Acta Diabetologica 47:4, pages 279-293.
Crossref
James Hare. (2010) Trafficking of amyloid β-precursor protein products C83 and C99 on the endocytic pathway. Biochemical and Biophysical Research Communications 401:2, pages 219-224.
Crossref
Marco Gobbi, Francesca Re, Mara Canovi, Marten Beeg, Maria Gregori, Silvia Sesana, Sandro Sonnino, Doriano Brogioli, Claudia Musicanti, Paolo Gasco, Mario Salmona & Massimo E. Masserini. (2010) Lipid-based nanoparticles with high binding affinity for amyloid-β1–42 peptide. Biomaterials 31:25, pages 6519-6529.
Crossref
James A. LenhartXiao LingRonak GandhiTai L. GuoPhillip M. Gerk, Darlene H. BrunzellShijun Zhang. (2010) “Clicked” Bivalent Ligands Containing Curcumin and Cholesterol As Multifunctional Aβ Oligomerization Inhibitors: Design, Synthesis, and Biological Characterization. Journal of Medicinal Chemistry 53:16, pages 6198-6209.
Crossref
Amit Shtainfeld, Tania Sheynis & Raz Jelinek. (2010) Specific Mutations Alter Fibrillation Kinetics, Fiber Morphologies, and Membrane Interactions of Pentapeptides Derived from Human Calcitonin. Biochemistry 49:25, pages 5299-5307.
Crossref
Paramita Chakrabarty, Pritam Das & Todd E. Golde. 2010. Protein Misfolding Diseases. Protein Misfolding Diseases 711 774 .
Marco Piccinini, Federica Scandroglio, Simona Prioni, Barbara Buccinnà, Nicoletta Loberto, Massimo Aureli, Vanna Chigorno, Elisa Lupino, Giovanni DeMarco, Annarosa Lomartire, Maria Teresa Rinaudo, Sandro Sonnino & Alessandro Prinetti. (2010) Deregulated Sphingolipid Metabolism and Membrane Organization in Neurodegenerative Disorders. Molecular Neurobiology 41:2-3, pages 314-340.
Crossref
Antoine Piau, F. Nourhashémi, C. Hein, C. Caillaud & B. Vellas. (2010) Progress in the development of new drugs in Alzheimer’s disease. The journal of nutrition, health & aging.
Crossref
Giuseppina CandoreMatteo BulatiCalogero CarusoLaura CastigliaGiuseppina Colonna-RomanoDanilo Di BonaGiovanni DuroDomenico LioDomenica MatrangaMariavaleria PellicanòClaudia RizzoGiovanni ScapagniniSonya Vasto. (2010) Inflammation, Cytokines, Immune Response, Apolipoprotein E, Cholesterol, and Oxidative Stress in Alzheimer Disease: Therapeutic Implications. Rejuvenation Research 13:2-3, pages 301-313.
Crossref
Akiko Oda, Akira Tamaoka & Wataru Araki. (2009) Oxidative stress up‐regulates presenilin 1 in lipid rafts in neuronal cells. Journal of Neuroscience Research 88:5, pages 1137-1145.
Crossref
Narendranath Reddy Chintagari, Amarjit Mishra, Lijing Su, Yang Wang, Sahlu Ayalew, Steven D. Hartson & Lin Liu. (2010) Vacuolar ATPase Regulates Surfactant Secretion in Rat Alveolar Type II Cells by Modulating Lamellar Body Calcium. PLoS ONE 5:2, pages e9228.
Crossref
Eloise Hudry, Debby Van Dam, Wim Kulik, Peter P De Deyn, Femke S Stet, Ornella Ahouansou, Abdellatif Benraiss, Andr? Delacourte, Pierre Bougn?res, Patrick Aubourg & Nathalie Cartier. (2010) Adeno-associated Virus Gene Therapy With Cholesterol 24-Hydroxylase Reduces the Amyloid Pathology Before or After the Onset of Amyloid Plaques in Mouse Models of Alzheimer's Disease. Molecular Therapy 18:1, pages 44-53.
Crossref
Ya Hui Hung, Ashley I. Bush & Robert Alan Cherny. (2009) Copper in the brain and Alzheimer’s disease. JBIC Journal of Biological Inorganic Chemistry 15:1, pages 61-76.
Crossref
Philine Schneider, Harald Hampel & Katharina Buerger. (2009) Biological Marker Candidates of Alzheimer's Disease in Blood, Plasma, and Serum. CNS Neuroscience & Therapeutics 15:4, pages 358-374.
Crossref
Garima Thakur, Miodrag Micic & Roger M. Leblanc. (2009) Surface chemistry of Alzheimer's disease: A Langmuir monolayer approach. Colloids and Surfaces B: Biointerfaces 74:2, pages 436-456.
Crossref
D. Grant Willhite & Stephen E. Wright. (2009) Detergent‐based isolation of yeast membrane rafts. Biochemistry and Molecular Biology Education 37:6, pages 349-354.
Crossref
Cristina M. Ram?rez, Miriam Gonz?lez, Mario D?az, Rafael Alonso, Isidre Ferrer, Gabriel Santpere, Berta Puig, Gundela Meyer & Raquel Marin. (2009) VDAC and ER? interaction in caveolae from human cortex is altered in Alzheimer's disease. Molecular and Cellular Neuroscience 42:3, pages 172-183.
Crossref
Ya Hui Hung, Elysia L. Robb, Irene Volitakis, Michael Ho, Genevieve Evin, Qiao-Xin Li, Janetta G. Culvenor, Colin L. Masters, Robert A. Cherny & Ashley I. Bush. (2009) Paradoxical Condensation of Copper with Elevated β-Amyloid in Lipid Rafts under Cellular Copper Deficiency Conditions. Journal of Biological Chemistry 284:33, pages 21899-21907.
Crossref
Jian Zhong, Chunhui Yang, Wenfu Zheng, Lixin Huang, Yuankai Hong, Lijun Wang & Yinlin Sha. (2009) Effects of Lipid Composition and Phase on the Membrane Interaction of the Prion Peptide 106–126 Amide. Biophysical Journal 96:11, pages 4610-4621.
Crossref
Gunter P. Eckert & Walter E. Müller. (2009) Presenilin 1 modifies lipid raft composition of neuronal membranes. Biochemical and Biophysical Research Communications 382:4, pages 673-677.
Crossref
Kulandaivelu S. Vetrivel, Xavier Meckler, Ying Chen, Phuong D. Nguyen, Nabil G. Seidah, Robert Vassar, Philip C. Wong, Masaki Fukata, Maria Z. Kounnas & Gopal Thinakaran. (2009) Alzheimer Disease Aβ Production in the Absence of S -Palmitoylation-dependent Targeting of BACE1 to Lipid Rafts . Journal of Biological Chemistry 284:6, pages 3793-3803.
Crossref
Haipeng Cheng, Kulandaivelu S. Vetrivel, Renaldo C. Drisdel, Xavier Meckler, Ping Gong, Jae Yoon Leem, Tong Li, Meghan Carter, Ying Chen, Phuong Nguyen, Takeshi Iwatsubo, Taisuke Tomita, Philip C. Wong, William N. Green, Maria Z. Kounnas & Gopal Thinakaran. (2009) S-Palmitoylation of γ-Secretase Subunits Nicastrin and APH-1. Journal of Biological Chemistry 284:3, pages 1373-1384.
Crossref
Mark G. Waugh & J. Justin Hsuan. 2009. Lipid Signaling Protocols. Lipid Signaling Protocols 1 12 .
Roberth Byström, Christopher Aisenbrey, Tomasz Borowik, Marcus Bokvist, Fredrick Lindström, Marc-Antoine Sani, Anders Olofsson & Gerhard Gröbner. (2008) Disordered Proteins: Biological Membranes as Two-Dimensional Aggregation Matrices. Cell Biochemistry and Biophysics 52:3, pages 175-189.
Crossref
C. Frank, S. Rufini, V. Tancredi, R. Forcina, D. Grossi & G. D'Arcangelo. (2008) Cholesterol depletion inhibits synaptic transmission and synaptic plasticity in rat hippocampus. Experimental Neurology 212:2, pages 407-414.
Crossref
Yury S. Tarahovsky, Evgueny N. Muzafarov & Yuri A. Kim. (2008) Rafts making and rafts braking: how plant flavonoids may control membrane heterogeneity. Molecular and Cellular Biochemistry 314:1-2, pages 65-71.
Crossref
Sonya Vasto, Giuseppina Candore, Florinda Listì, Carmela Rita Balistreri, Giuseppina Colonna-Romano, Marco Malavolta, Domenico Lio, Domenico Nuzzo, Eugenio Mocchegiani, Danilo Di Bona & Calogero Caruso. (2008) Inflammation, genes and zinc in Alzheimer's disease. Brain Research Reviews 58:1, pages 96-105.
Crossref
Eline M. van der Beek & Patrick J.G.H. Kamphuis. (2008) The potential role of nutritional components in the management of Alzheimer's Disease. European Journal of Pharmacology 585:1, pages 197-207.
Crossref
Christine A.F. von Arnim, Bjoern von Einem, Petra Weber, Michael Wagner, Daniel Schwanzar, Robert Spoelgen, Wolfgang L.S. Strauss & Herbert Schneckenburger. (2008) Impact of cholesterol level upon APP and BACE proximity and APP cleavage. Biochemical and Biophysical Research Communications 370:2, pages 207-212.
Crossref
Lawrence RajendranAnja SchneiderGeorg SchlechtingenSebastian WeidlichJonas RiesTobias BraxmeierPetra SchwilleJörg B. SchulzCornelia SchroederMikael SimonsGary JenningsHans-Joachim KnölkerKai Simons. (2008) Efficient Inhibition of the Alzheimer's Disease β-Secretase by Membrane Targeting. Science 320:5875, pages 520-523.
Crossref
Alba Rebollo, Jordi Pou & Marta Alegret. (2008) Cholesterol lowering and beyond: role of statins in Alzheimer’s disease. Aging Health 4:2, pages 171-180.
Crossref
Nigel M. Hooper & Anthony J. Turner. (2008) A new take on prions: preventing Alzheimer's disease. Trends in Biochemical Sciences 33:4, pages 151-155.
Crossref
Ji‐Yeun Hur, Hedvig Welander, Homira Behbahani, Mikio Aoki, Jenny Frånberg, Bengt Winblad, Susanne Frykman & Lars O. Tjernberg. (2008) Active γ‐secretase is localized to detergent‐resistant membranes in human brain. The FEBS Journal 275:6, pages 1174-1187.
Crossref
Huaqi Xiong, Debbie Callaghan, Aimee Jones, Douglas G. Walker, Lih-Fen Lue, Thomas G. Beach, Lucia I. Sue, John Woulfe, Huaxi Xu, Danica B. Stanimirovic & Wandong Zhang. (2008) Cholesterol retention in Alzheimer's brain is responsible for high β- and γ-secretase activities and Aβ production. Neurobiology of Disease 29:3, pages 422-437.
Crossref
Xu Hou, Adam Mechler, Lisandra L. Martin, Marie-Isabel Aguilar & David H. Small. (2008) Cholesterol and anionic phospholipids increase the binding of amyloidogenic transthyretin to lipid membranes. Biochimica et Biophysica Acta (BBA) - Biomembranes 1778:1, pages 198-205.
Crossref
Mark M. Banaszak Holl. 2008. Phase Transitions in Cell Biology. Phase Transitions in Cell Biology 171 181 .
Anders Olofsson, Tomasz Borowik, Gerhard Gröbner & A. Elisabeth Sauer-Eriksson. (2007) Negatively Charged Phospholipid Membranes Induce Amyloid Formation of Medin via an α-Helical Intermediate. Journal of Molecular Biology 374:1, pages 186-194.
Crossref
Slawomir Wojcik, W. King Engel, Riqiang Yan, Janis McFerrin & Valerie Askanas. (2007) NOGO is increased and binds to BACE1 in sporadic inclusion-body myositis and in AβPP-overexpressing cultured human muscle fibers. Acta Neuropathologica 114:5, pages 517-526.
Crossref
Áine T. Behan, Martina Foy, Kieran Wynne, Michael Clarke, Matthew Sullivan, David R. Cotter & Patricia B. Maguire. (2007) Analysis of membrane microdomain‐associated proteins in the insular cortex of post‐mortem human brain. PROTEOMICS – Clinical Applications 1:10, pages 1324-1331.
Crossref
Omar Bakht, Javier Delgado, Francisco Amat-Guerri, A. Ulises Acuña & Erwin London. (2007) The phenyltetraene lysophospholipid analog PTE-ET-18-OMe as a fluorescent anisotropy probe of liquid ordered membrane domains (lipid rafts) and ceramide-rich membrane domains. Biochimica et Biophysica Acta (BBA) - Biomembranes 1768:9, pages 2213-2221.
Crossref
Katsumi Matsuzaki. (2007) Physicochemical interactions of amyloid ?-peptide with lipid bilayers. Biochimica et Biophysica Acta (BBA) - Biomembranes 1768:8, pages 1935-1942.
Crossref
Martin Gamerdinger, Angela B. Clement & Christian Behl. (2007) Cholesterol-Like Effects of Selective Cyclooxygenase Inhibitors and Fibrates on Cellular Membranes and Amyloid-β Production. Molecular Pharmacology 72:1, pages 141-151.
Crossref
Patrick C. Reid, Yasuomi Urano, Tatsuhiko Kodama & Takao Hamakubo. (2007) Alzheimer's Disease: cholesterol, membrane rafts, isoprenoids and statins. Journal of Cellular and Molecular Medicine 11:3, pages 383-392.
Crossref
Vincenzo Giordano, Gianfranco Peluso, Maurizio Iannuccelli, Paola Benatti, Raffaella Nicolai & Menotti Calvani. (2006) Systemic and Brain Metabolic Dysfunction as a New Paradigm for Approaching Alzheimer’s Dementia. Neurochemical Research 32:4-5, pages 555-567.
Crossref
A.J. Turner & N.N. Nalivaeva. 2007. Neuroinflammation in Neuronal Death and Repair. Neuroinflammation in Neuronal Death and Repair 113 135 .
A. Claudio CuelloNigel M. Hooper & Emma R. L. C. Vardy. 2007. Pharmacological Mechanisms in Alzheimer's Therapeutics. Pharmacological Mechanisms in Alzheimer's Therapeutics 113 124 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.